The potential pathogenic role of Mycobacterium tuberculosis H37Rv fadD33, a gene encoding an acyl-CoA synthase that is underexpressed in the attenuated strain H37Ra, was investigated. In a first approach, fadD33 was cloned and expressed in strain H37Ra to restore gene expression and fadD33-complemented bacteria were used to investigate whether fadD33 might confer any growth advantage to M. tuberculosis H37Ra in an infection model of BALB/c mice. No differences were found in the growth rates of M. tuberculosis H37Rv, H37Ra and fadD33-complemented H37Ra in the lungs and spleen. In contrast, in the liver, where the attenuated strain H37Ra showed impaired growth compared to the virulent strain H37Rv, complementation of the attenuated strain H37Ra with fadD33 restored bacterial replication. In a further approach, the fadD33 gene of strain H37Rv was disrupted by allelic exchange mutagenesis and the virulence of the mutant strain was tested by mouse infection. It was found that disruption of fadD33 decreased M. tuberculosis H37Rv growth in the liver, but not in the lungs or spleen, and complementation of the fadD33-disrupted mutant with fadD33 restored bacterial replication in the liver, but did not affect replication in the lungs and spleen. These findings suggest that fadD33 plays a role in M. tuberculosis virulence by supporting bacterial growth in the liver.
AlbertiniA. M.,
CaramoriT.,
ScoffoneF.,
ScottiC.,
GalizziA.
1995; Sequence around the 159° region of the Bacillus subtilis genome: the pksX locus spans 33·6 kb. Microbiology 141:299–309[CrossRef]
CamachoL. R.,
EnsergueixD.,
PerezE.,
GicquelB.,
GuilhotC.
1999; Identification of a virulence gene cluster of Mycobacterium tuberculosis by signature-tagged trasposon mutagenesis. Mol Microbiol 34:257–267[CrossRef]
ClarkD. P.,
CronanJ. E.Jrothers1996; Two-carbon compounds and fatty acids as carbon sources. In Escherichia coli and Salmonella: Cellular and Molecular Biology, 2nd edn. pp 343–357 Edited by
NeidhardtF. C.
Washington, DC: American Society for Microbiology;
ColeS. T.,
BroschR.,
ParkhillJ.39 other authors1998; Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393:537–544[CrossRef]
De VossJ. J.,
RutterK.,
SchoederB. G.,
SuH.,
ZhuY.,
BarryC. E.III.
2000; The salicylate-derived mycobactin siderophores of Mycobacterium tuberculosis are essential for growth in macrophages. Proc Natl Acad Sci USA 97:1252–1257[CrossRef]
Donnelly-WuM. K.,
JacobsW. R.Jr,
HatfullG. F.
1993; Superinfection immunity of mycobacteriophage L5: applications for genetic transformation of mycobacteria. Mol Microbiol 7:407–17[CrossRef]
GarbeT. R.,
BarathiJ.,
BarniniS.,
ZhangY.,
Abou-ZeidC.,
TangD.,
MukherjeeR.,
YoungD. B.
1994; Transformation of mycobacterial species using hygromycin resistance as selectable marker. Microbiology 140:133–138[CrossRef]
GeorgeK. M.,
ChatterjeeD.,
GunawardanaG.,
WeltyD.,
HaymanJ.,
LeeR.,
SmallP. L.
1999; Mycolactone: a polyketide toxin from Mycobacterium ulcerans required for virulence. Science 283:854–857[CrossRef]
GrahamJ. E.,
Clark-CurtissJ. E.
1999; Identification of Mycobacterium tuberculosis RNAs synthesized in response to phagocytosis by human macrophages by selective capture of transcribed sequences (SCOTS). Proc Natl Acad Sci U S A 96:11554–11559[CrossRef]
KingerA. K.,
TyagiJ. S.
1993; Identification and cloning of genes differentially expressed in the virulent strain of Mycobacterium tuberculosis
. Gene 131:113–117[CrossRef]
KolattukudyP. E.,
FernandesN. D.,
AzadA. K.,
FitzmauriceA. M.,
SirakovaT. D.
1997; Biochemistry and molecular genetics of cell-wall lipid biosynthesis in mycobacteria. Mol Microbiol 24:263–270[CrossRef]
LariN.,
RindiL.,
GarzelliC.
2001; Identification of one insertion site of IS 6110 in Mycobacterium tuberculosis H37Ra and analysis of the RvD2 deletion in M. tuberculosis clinical isolates. J Med Microbiol 50:805–811
ManganelliR.,
VoskuilM. I.,
SchoolnikG. K.,
SmithI.
2001; The Mycobacterium tuberculosis ECF sigma factor σE: role in global gene expression and survival in macrophages. Mol Microbiol 41:423–437[CrossRef]
McDonoughK. A.,
KressY.,
BloomB. R.
1993; Pathogenesis of tuberculosis: interaction of Mycobacterium tuberculosis with macrophages. Infect Immun 61:2763–2773
McKinneyJ. D.,
Höner zu BentrupK.,
Muòoz-EliasE. J.7 other authors2000; Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase. Nature 406:735–738[CrossRef]
MedinaE.,
NorthR. J.
1998; Resistance ranking of some common inbred mouse strains to Mycobacterium tuberculosis and relationship to major histocomatibility complex haplotype and Nramp1 genotype. Immunology 93:270–274
MotamediH.,
CaiS. J.,
ShafieeA.,
EllistonK. O.
1997; Structural organization of a multifunctional polyketide synthase involved in the biosynthesis of the macrolide immunosuppressant FK506. Eur J Biochem 244:74–80[CrossRef]
NorthR. J.,
IzzoA. A.
1993; Mycobacterial virulence. Virulent strains of Mycobacterium tuberculosis have faster in vivo doubling times and are better equipped to resist growth-inhibiting functions of macrophages in the presence and absence of specific immunity. J Exp Med 177:1723–1733[CrossRef]
NunnW. D.
others1987; Two-carbon compounds and fatty acids as carbon sources. In Escherichia coli and Salmonella: Cellular and Molecular Biology pp 285–301, 2nd edn. Edited by
NeidhardtF. C.
Washington, DC: American Society for Microbiology;
PascopellaL.,
CollinsF. M.,
MartinJ. M.,
LeeM. H.,
HatfullG. F.,
StoverC. K.,
BloomB. R.,
JacobsW. R.Jr1994; Use of in vivo complementation in Mycobacterium tuberculosis to identify a genomic fragment associated with virulence. Infect Immun 62:1313–1319
RindiL.,
LariN.,
GilM. G.,
GarzelliC.
1998; Oligo(dT)-primed synthesis of cDNA by reverse transcriptase in mycobacteria. Biochem Biophys Res Commun 248:216–218[CrossRef]
RindiL.,
LariN.,
GarzelliC.
2001; Genes of Mycobacterium tuberculosis H37Rv downregulated in the attenuated strain H37Ra are restricted to M. tuberculosis complex species. New Microbiol 24:289–294
Rivera-MarreroC. A.,
BurroughsM. A.,
MasseR. A.,
VannbergF. O.,
LeinbachD. L.,
RomanJ.,
MurtaghJ. J.Jr1998; Identifications of genes differentially expressed in Mycobacterium tuberculosis by differential display PCR. Microb Pathog 25:307–316[CrossRef]
SharmaV.,
SharmaS.,
Hoener zu BentrupK.,
McKinneyJ. D.,
RussellD. G.,
JacobsW. R.Jr,
SacchettiniJ. C.
2000; Structure of isocitrate lyase, a persistence factor of Mycobacterium tuberculosis
. Nat Struct Biol 7:663–668[CrossRef]
SteenkenW.Jr,
OatwayW. H.Jr,
PetroffS. A.
1934; Biological studies of the tubercle bacillus. III. Dissociation and pathogenicity of the R and S variants of the human tubercle bacillus (H37). J Exp Med 60:515–540[CrossRef]
ZhangM.,
GongJ.,
LinY.,
BarnesP. F.
1998; Growth of virulent and avirulent Mycobacterium tuberculosis strains in human macrophages. Infect Immun 66:794–799